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Germ cell tumors constitute up to 20% of all mediastinal masses.1,2 Their symptoms are commonly caused by compression or invasion 
of surrounding structures, and patients usually present 
with weight loss, fatigue, respiratory distress, and py-
rexia. The association of mediastinal germ cell tumors 
with hematological disorders including leukaemias, my-
elodysplastic syndrome, malignant histiocytosis and he-
mophagocytic syndrome had been documented.3,4 We 
present a patient who had a mediastinal endodermal si-
nus tumor (EST) (known also as yolk sac tumor) who 
developed pancytopenia due to marked hemophago-
cytic syndrome.
CASE 
A 24-year-old male patient presented with a 3-month 
history of fever, dry cough and weight loss. On exami-
nation the right side of the chest was dull on percus-
sion and breath sounds were absent. His chest x-ray 
and computerized tomography (CT) scan showed a 
large mediastinal tumor with right-sided pleural effu-
sion (Figure 1). Laboratory investigations revealed pro-
nounced hematological abnormalities, including low 
hemoglobin (5 g/dL, normal range: 12-17 g/dL), leu-
kopenia (WBC count of 2.7×109/L, normal range: 4.5-
11×109), anemia (RBC count of 2.09×1012/L, normal 
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the association of endodermal sinus tumor, known also as yolk sac tumor, of the mediastinum with 
hemophagocytic syndrome is exceedingly rare with only a few cases on record. We report a 24-year-
old male who had a large mediastinal germ cell tumor, proven to be an endodermal sinus tumor on 
biopsy. the patient developed pancytopenia and coagulopathy related to associated hemophagocytic 
syndrome, with a fatal outcome. a brief review of the relevant literature is presented as well.
range: 4.3-5.7×1012/L) and thrombocytopenia (platelet 
count of 6×109/L, normal range: 150-400×109/L). D-
dimers were significantly increased (1335 mg/L, nor-
mal: 0.5 mg/L). Alpha-fetoprotein levels were mark-
edly elevated (12 000 ng/mL, normal: 44 ng/L). A CT-
guided needle biopsy of the mediastinal mass was done 
after blood and platelet transfusion. The histopathology 
result showed an endodermal sinus tumor (Figure 2). 
Bone marrow biopsy revealed many macrophages with 
engulfed red blood cells present within their cytoplasm 
(Figure 3). One liter of hemorrhagic pleural fluid was 
drained from the right pleural cavity. A cytological ex-
amination was negative for malignant cells. The patient 
was placed on steroids and a chemotherapy regimen of 
cisplatin, etoposide and bleomycin. Following the first 
cycle of chemotherapy his conditioned deteriorated. It 
was decided to stop further chemotherapy as he was 
not in condition to withstand a second cycle of chemo-
therapy. The patient was referred to palliative care, and 
he expired one week later.
DISCUSSION
Mediastinal germ cell tumors are rare. However, they 
are the most common location for primary extragonadal 
germ cell lesions, representing 10% to 20% of all neo-
plasms in this location 1 and up to 15% of anterior me-
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Figure 1. a. axial contrast enhanced computerized (CT) scan of chest showing a large 
heterogeneous attenuated mass in the right paramediastinal area abutting the heart and 
displacing it to the left. The right and left atrial chambers are compressed by the tumor. 
There is a large right pleural effusion and a metastatic nodule in the left lung. b. Coronary 
reconstructed image of the same patient showing a mass extending from the level of 
superior vena cava to the diaphragm compressing the superior vena cava heart and 
inferior vena cava. 
diastinal tumors.2 In a review of 322 cases of primary 
germ cell tumors of the mediastinum, the distribution of 
tumor types were 44% teratomas, 37% seminomas, 16% 
non-seminomatous germ cell tumors including endoder-
mal sinus tumors (EST), and 3% combined tumors.5
There are several reported cases of EST of the medi-
astinum, including a short series of ten cases6 and seven 
cases7 as well as a large series of 38 cases from the Armed 
Forces Institute of Pathology (AFIP).8 These studies em-
phasized the predilection of this tumor to affect young 
adult males as in the present case, with a mean age of 26 
to 30 years, and the lethal outcome of the tumor, par-
ticularly when it is unresectable. The aggressive nature of 
primary non-seminomatous tumors of the mediastinum 
is clear, with 72% of the patients dead of their tumor 6 
to 36 months after diagnosis despite aggressive therapy.8 
The association of mediastinal EST and other non-sem-
inomatous germ cells with hematological disorders and 
malignancies had been documented in several reports. In 
one large study of 635 patients with extragonadal germ 
cell tumors, including 341 mediastinal tumors, treated 
at major hospitals in the USA and Europe, 17 patients 
were found to have hematological disorders. All of these 
patients had a mediastinal non-seminomatous germ cell 
tumor. The hematological conditions include myelodys-
plastic syndrome (5 cases), acute megakaryocytic leuke-
mia (5 cases), acute myeloblastic leukemia (1 case), acute 
myelomonocytic leukemia (1 case), acute undifferenti-
ated leukemia (2 cases), mast cell leukemia (2 cases) and 
histiocytosis (1 case). All these patients died within two 
years after diagnosis of their hematological malignancy 
with a median survival time of 5 months (range 0-16 
months).3 In another review of patients with mediastinal 
germ cell tumor who received chemotherapy prior to the 
development of hematological malignancies, a total of 19 
patients with non-seminomatous germ cell tumors, in-
cluding 3 patients who had EST component, developed 
various types of acute myelogenous leukemia.9 
In a third study from the University of Indiana, 16 
patients had mediastinal germ cell tumors and hemato-
logical neoplasms. All patients had non-seminomatous 
germ cell tumors, with EST or embryonal carcinoma 
in combination with teratoma was quite common. The 
two most common hematological neoplasms in this 
series were acute megakaryocytic leukemia and malig-
nant histiocytosis.10 This association between medias-
tinal non-seminomatous germ cell tumors, particularly 
EST, prompted Orazi and his colleagues to look into a 
hypothesis postulating that these leukemic conditions 
originated from progenitor cells within these tumors 
that were capable of undergoing hematopoietic differ-
entiation. They examined histological tumor material 
from six patients using immunohistochemical mark-
ers for different bone marrow cell lineages. They found 
identifiable hematological cells within the yolk sac tu-
mor component of four patients.11 
A case of unusual association of mediastinal terato-
ma with EST and myelomonocytic leukemia associated 
with Klinefelter syndrome was reported in a 14-year-
old male who underwent thoracotomy and biopsy of 
the mediastinal tumor, but died a week later.12
In another case, an unusual association of a medi-
astinal mixed germ cell tumor containing elements of 
seminoma, immature teratoma, EST, embryonal carci-
noma and angiosarcoma with a histiocytic sarcoma of 
the spleen occurred in a 15-year-old boy who presented 
with chest pain.13
The association of mediastinal EST or other non-
seminomatous germ cell tumors with the hemophago-
cytic syndrome has been documented in sporadic case 
reports. This syndrome is synonymous with hemo-
phagocytic lymphohistiocytosis, can be of primary 
or familial with autosomal recessive inheritance,14 or 
secondarily associated with infections,15,16 malignan-
cies and rheumatologic disorders.17 The pathophysi-
ology of this syndrome appears to involve the marked 
activation of lymphocytes and macrophages, with an 
abnormal expression of perforin, hMunc13-4 (UNC 
13D) and syntaxin 11, all cytotoxic granule associated 
proteins,18 resulting in a release of cytokines produced 
by these cells including IFN-gamma, IL-6, IL-10, IL-
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12, IL-16, IL-18, and TNF-alpha. This can result in 
organ dysfunction due to organ infiltration and ex-
cessive phagocytosis of blood cells and their precur-
sors in bone marrow, liver, spleen and other organs.19 
When hemophagocytic syndrome is associated with 
non-malignant pathology such as viral, bacterial, pro-
tozoal, and collagen disorders, it usually resolves once 
the basic disease is treated.15 However, when it is as-
sociated with malignancy, the prognosis is very poor 
and the median survival is 3 to 4 months from the 
onset of disease.
Hemophagocytic syndrome associated with medi-
astinal germ cell tumor is very rare. To the best of our 
knowledge thirteen cases have been reported in the 
literature to date, including four cases associated with 
reactive hemophagocytic syndrome while the rest were 
associated with malignant histiocytosis or histiocytic 
sarcoma.4, 20-29 
Our case is the fifth case of reactive hemophagocytic 
syndrome associated with mediastinal non-seminoma-
tous germ cell tumor that is composed mainly of endo-
dermal sinus (yolk sac) tumor. The outcome of these 
tumors in association with hemophagocytic syndrome 
is very poor irrespective of metastatic status, and pa-
tients survive only for a few months from the onset of 
disease despite the various treatment modalities in-
cluding steroids immunotherapy and chemotherapy. 
When mediastinal germ cell tumors are not associated 
with hemophagocytic syndrome, the 5-year survival is 
50% with conventional chemotherapy. There are two 
chemotherapy regimens: conventional alone and high 
dose chemotherapy (HDCT) with autologus stem cell 
transplantation, which have been given in many trials. 
Randomized trials in the United States and Europe 
using HDCT in patients at poor risk with metastasis, 
did not show any survival benefit. When non-semino-
matous germ cell tumors are not associated with hemo-
phagocytic syndrome the 5-year survival is 50% with 
conventional chemotherapy.30
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Figure 2 Histological appearance of an endodermal sinus tumor of the mediastinum 
obtained by core biopsy. a Schiller-duval body, typical of this tumor, is present at the 
center (H&e ×400).
Figure 3. bone marrow aspirate showing hemophagocytosis with large macrophages 
phagocytosing erythrocytes. (Giemsa stain ×1000).
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